Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William F Simonds

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Endocrine-Related Cancer|February 23, 2018
Frequency and consequence of the recurrent <i>YY1</i> p.T372R mutation in sporadic insulinomasVaishali I Parekh, Sita D Modali, James Welch, et al.
Medicine|January 25, 2002
Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindredsWilliam F Simonds, Laura A James-Newton, Sunita K Agarwal, et al.
Journal of Biotechnology|September 7, 2014
Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporterJian-Hua Zhang, Mritunjay Pandey, John F Kahler, et al.
The Journal of Clinical Endocrinology and Metabolism|June 20, 2023
Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor SyndromeRana Tora, James Welch, Jian Sun, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 26, 2006
Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutationThomas G Kelly, Trisha M Shattuck, Miguel Reyes-Mugica, et al.
Oncogene|March 1, 2005
topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damageLing Lin, Toshinori Ozaki, Yuki Takada, et al.
The Journal of Clinical Endocrinology and Metabolism|October 25, 2012
Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1Allison B Weisbrod, Naris Nilubol, Lee S Weinstein, et al.
Annals of Surgical Oncology|July 29, 2016
Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary HyperparathyroidismXavier M Keutgen, Naris Nilubol, Sunita Agarwal, et al.
Clinical Endocrinology|April 28, 2011
Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivationPhilippe Caron, William F Simonds, Jean-Christophe Maiza, et al.
Journal of the Endocrine Society|December 22, 2017
Ethnicity of Patients With Germline <i>GCM2</i>-Activating Variants and Primary HyperparathyroidismBin Guan, James M Welch, Meghana Vemulapalli, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Endocrine-Related Cancer|February 23, 2018
Frequency and consequence of the recurrent <i>YY1</i> p.T372R mutation in sporadic insulinomasVaishali I Parekh, Sita D Modali, James Welch, et al.
Medicine|January 25, 2002
Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindredsWilliam F Simonds, Laura A James-Newton, Sunita K Agarwal, et al.
Journal of Biotechnology|September 7, 2014
Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporterJian-Hua Zhang, Mritunjay Pandey, John F Kahler, et al.
The Journal of Clinical Endocrinology and Metabolism|June 20, 2023
Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor SyndromeRana Tora, James Welch, Jian Sun, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 26, 2006
Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutationThomas G Kelly, Trisha M Shattuck, Miguel Reyes-Mugica, et al.
Oncogene|March 1, 2005
topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damageLing Lin, Toshinori Ozaki, Yuki Takada, et al.
The Journal of Clinical Endocrinology and Metabolism|October 25, 2012
Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1Allison B Weisbrod, Naris Nilubol, Lee S Weinstein, et al.
Annals of Surgical Oncology|July 29, 2016
Reoperative Surgery in Patients with Multiple Endocrine Neoplasia Type 1 Associated Primary HyperparathyroidismXavier M Keutgen, Naris Nilubol, Sunita Agarwal, et al.
Clinical Endocrinology|April 28, 2011
Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivationPhilippe Caron, William F Simonds, Jean-Christophe Maiza, et al.
Journal of the Endocrine Society|December 22, 2017
Ethnicity of Patients With Germline <i>GCM2</i>-Activating Variants and Primary HyperparathyroidismBin Guan, James M Welch, Meghana Vemulapalli, et al.
Pageof 10